Akut mieloid leukémia (AML): vizsgálatok itt: India

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 4. fázisTaking people
  Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

  Where

  Bengaluru, Bhubaneswar, Chennai, Gurgaon, Hyderabad, Mumbai, New Delhi, Pune, Thiruvananthapuram, Vellore

  Életkor

  18 év and over

  People

  100

  Run by

  AbbVie

  See details and how to joinNCT07044687